Success Story: Our Firm Helped an Indian Gastroenterology and Hepatology Fellow Secure an NIW Approval
On January 24th, 2025, we received another EB-2 NIW (National Interest Waiver) approval for a Gastroenterology and Hepatology Fellow in the Field of Gastroenterology (Approval Notice).
General Field: Gastroenterology
Position at the Time of Case Filing: Gastroenterology and Hepatology Fellow
Country of Origin: India
State of Residence at the Time of Filing: Minnesota
Approval Notice Date: January 24th, 2025
Processing Time: 3 months, 7 days
Case Summary:
We are pleased to share another success story of a client whose I-140 NIW petition was recently approved.
Our client, who holds an M.B.B.S., is an accomplished physician-scientist specializing in gastroenterology. His proposed endeavor is to advance research focused on developing cutting-edge molecular diagnostic tools, pioneering innovative treatment strategies, and implementing comprehensive patient care models. Specifically, his work aims to study risk factors and transform the early diagnosis and management of gastrointestinal and liver diseases, including cancer. This area of research carries clear substantial merit and national importance, as it directly supports improved health outcomes, reduced healthcare costs, and advances in precision medicine in the United States.
In support of his petition, we emphasized his outstanding academic and professional record, which includes 34 peer-reviewed journal articles (11 of them first- or co-first-authored) and 65 conference abstracts (29 of them first-authored). His body of work has already been cited 1,367 times by other researchers, reflecting its significant influence in the field. Further demonstrating his prominence, he has been invited to complete at least 28 peer reviews for leading medical journals, a role reserved for recognized experts in the discipline. His research has also been backed by major funding from the United Kingdom Research and Innovation Medical Research Council, further underscoring its recognized value within the international scientific community.
To further strengthen the case, we submitted two letters of recommendation from respected experts in the field. These letters confirmed the originality, importance, and broad impact of his work, with recommenders underscoring his ability to continue driving progress in gastroenterology and liver disease research. One recommender noted:
“Ensuring that [Client’s] work proceeds is thus not only important to the field, but to the United States as well.”
By presenting this compelling evidence, we successfully demonstrated that his proposed endeavor has substantial merit and national importance, that he is exceptionally well-positioned to advance it, and that granting a waiver of the job offer requirement is in the best interest of the United States.
We are proud to have assisted in securing this approval and look forward to seeing the continued impact of his pioneering work in gastroenterology.

